ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 327 filers reported holding ROYALTY PHARMA PLC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,410,250 | +43.5% | 162,500 | +62.5% | 0.01% | +42.9% |
| Q2 2023 | $3,074,000 | +288.9% | 100,000 | +400.0% | 0.01% | +600.0% |
| Q4 2022 | $790,400 | -1.7% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $804,000 | -88.8% | 20,000 | -88.9% | 0.00% | -83.3% |
| Q4 2021 | $7,173,000 | -13.8% | 180,000 | -21.8% | 0.01% | 0.0% |
| Q3 2021 | $8,319,000 | +304.2% | 230,200 | +358.6% | 0.01% | +200.0% |
| Q2 2021 | $2,058,000 | -6.7% | 50,200 | -0.7% | 0.00% | 0.0% |
| Q1 2021 | $2,205,000 | +5.0% | 50,543 | +16.8% | 0.00% | 0.0% |
| Q2 2020 | $2,101,000 | – | 43,276 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |